Market Research Logo

US Market Report for Lancet and Lancing Devices 2017 - MedCore

US Market Report for Lancet and Lancing Devices 2017 - MedCore

The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices are used by individuals who use personal meters to perform self-monitoring blood glucose (SMBG) on a daily basis. CMS competitive bidding had a significant impact on the personal lancet and lancing device market after substantial reimbursement cuts in July 2013 and July 2016, respectively. Lancet reuse is also a limiter of growth in the personal segment. The professional market comprises safety lancets, which are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Safety lancets are necessary to avoid the risk of needlestick injuries and the spread of blood-borne pathogens.

A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip. Many lancets come as a component of blood glucose monitoring kits, and can be adjusted for injection depth. Reusable lancets are not as effective as they are more dull and painful and increase the risk of infection.


EXECUTIVE SUMMARY
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
LANCET AND LANCING DEVICE MARKET
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Lancet and Lancing Device Market
3.3.1.1 Personal Lancet and Lancing Device Market
3.3.1.2 Professional Lancet and Lancing Device Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023
Chart 3 1: Lancet and Lancing Device Market by Segment, U.S., 2013 – 2023
Chart 3 2: Lancet and Lancing Device Market Breakdown, U.S., 2016
Chart 3 3: Lancet and Lancing Device Market Breakdown, U.S.,2023
Chart 3 4: Total Lancet and Lancing Device Market, U.S., 2013 – 2023
Chart 3 5: Personal Lancet and Lancing Device Market, U.S., 2013 – 2023
Chart 3 6: Professional Lancet and Lancing Device Market, U.S., 2013 – 2023
Chart 3 7: Leading Competitors, Lancet and Lancing Device Market, U.S., 2016
List of Figures
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2)
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2)
Figure 1 11: Key Report Updates
Figure 1 12: Version History
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016
Figure 3 1: Lancet and Lancing Device Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 3 2: Total Lancet and Lancing Device Market, U.S., 2013 – 2023
Figure 3 3: Personal Lancet and Lancing Device Market, U.S., 2013 – 2023
Figure 3 4: Professional Lancet and Lancing Device Market, U.S., 2013 – 2023
Figure 3 5: Drivers and Limiters, Lancet and Lancing Device Market, U.S., 2016
Figure 3 6: Leading Competitors, Lancet and Lancing Device Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report